THE DECISION ON THE AMENDMENT OF THE DECISION ON PRICING OF MEDICINAL PRODUCTS FOR HUMAN USE HAS BEEN PUBLISHED.
- Nuri Melih İnce
- Oct 24, 2024
- 1 min read
The Decision on the Amendment of the Decision on Pricing of Medicinal Products for Human Use (“Amendment Decision”) has been published in the Official Gazette dated 24.10.2024.The significant increases and changes implemented by the Amendment Decision, which will enter into force on 25.10.2024, are explained below.
Warehouse and pharmacist profit rates to be applied for the determination of retail sale prices of the products and price thresholds have been re-determined as follows:
Importantly, by the Amendment Decision, the value of 1 (one) Euro in Turkish Lira to be used in the pricing of medicinal products for human use was increased by 23,5% in October 2024 and set as 21.6721 TRY. It is also included in the regulation that this value will continue to be applied for the year 2025 and that no new assessment of 1 (one) Euro will be made for the year 2025.
